Home / Services / Pharmaceutical Product Risk and Recall Services / Pharmaceutical Recall Preparedness and Crisis Management
Pharmaceutical Recall Preparedness and Crisis Management
RQA helps pharmaceutical companies develop, review, train and test recall and crisis-management arrangements, so that teams can make informed decisions and respond effectively when an issue arises.
Build recall arrangements that support patient safety, regulatory compliance and business continuity
Pharmaceutical recalls can involve significant patient-safety, regulatory, operational and financial consequences. The extent of the exposure depends not only on the nature of the product issue, but also on where the product has been distributed, the populations affected, the company’s ability to trace impacted batches and how quickly the organisation can investigate, make decisions and communicate with stakeholders.
Pharmaceutical recall plan development and review
A documented procedure is only one part of recall preparedness. Pharmaceutical companies also need people who understand their responsibilities, reliable information on which to base decisions and a team that can operate effectively during a fast-moving incident.
RQA provides practical, tailored support to pharmaceutical manufacturers, biotechnology businesses, importers, distributors and other life-sciences organisations. We can develop a pharmaceutical recall plan from the ground up or independently review an existing plan against regulatory expectations, industry good practice and the realities of the company’s operation.
Our consultants consider whether the plan provides a clear and workable framework for:
- detecting and escalating potential product issues;
- establishing the recall or crisis-management team;
- defining roles, responsibilities and delegated authority;
- conducting incident and health-hazard risk assessments;
- making and documenting recall decisions;
- identifying affected products, batches and markets;
- reconciling manufactured, distributed and recovered quantities;
- notifying regulators and other relevant authorities;
- communicating with customers, healthcare professionals and patients;
- managing returned or quarantined products;
- maintaining a complete, time-stamped incident log;
- coordinating with suppliers and outsourced partners; and
- completing effectiveness checks, root-cause investigations and post-incident reviews.
Following a review, RQA provides a written report identifying gaps and recommending practical improvements. Where required, we can also help restructure or update the plan and its supporting documents.
Pharmaceutical product recall training
RQA delivers tailored recall training for the people who may need to manage or support a pharmaceutical recall. Training can be adapted to the company’s products, markets, procedures, regulatory environment and level of experience.
Subjects may include:
- pharmaceutical recall principles and regulatory expectations;
- roles of regulators and other authorities;
- recall classifications and reporting requirements;
- escalation and recall decision-making;
- health-hazard and incident risk assessment;
- batch traceability and reconciliation;
- roles and responsibilities within the recall team;
- engagement with healthcare professionals, customers and supply-chain partners;
- crisis communications and stakeholder management;
- incident logging and decision records;
- lessons from relevant recall case studies; and
- practical use of the company’s own recall procedures.
Courses can include facilitated discussions, case studies and tabletop exercises to help participants apply the learning to realistic situations.
Training is appropriate for colleagues across Quality Assurance, regulatory affairs, pharmacovigilance, medical, manufacturing, supply chain, distribution, customer services, legal, communications and senior management.
Mock pharmaceutical recall simulations
A simulation tests whether the recall plan, the people and the supporting systems work together under pressure.
RQA develops realistic, scenario-based exercises tailored to the organisation’s products and risk profile. A scenario might involve contamination, sterility concerns, an out-of-specification result, a labelling or packaging error, temperature excursion, falsification, an adverse-event signal, a supplier failure or another issue capable of triggering regulatory action or a market recall.
During the exercise, the team receives new information as the scenario develops. This may include calls and messages from regulators, laboratories, distributors, healthcare professionals, customers, suppliers or the media. Participants must assess the information, establish the potential patient and business impact, make decisions and coordinate an appropriate response.
The exercise can examine:
- escalation and activation of the recall team;
- team leadership and decision-making;
- use of the recall plan;
- health-hazard and incident risk assessment;
- batch and distribution traceability;
- engagement with regulators;
- management of suppliers and contract partners;
- customer, healthcare-professional and patient communications;
- media and social-media response;
- incident logging and governance; and
- the team’s ability to respond to changing circumstances.
Following the simulation, RQA provides a structured debrief and written report identifying strengths, gaps and prioritised recommendations for improvement.
Pharmaceutical crisis management
Some pharmaceutical incidents extend beyond the operational management of a recall. Patient harm, regulatory intervention, product shortages, litigation, intense media scrutiny or loss of stakeholder confidence can quickly escalate an event into a wider corporate crisis.
RQA helps pharmaceutical businesses develop and strengthen crisis-management arrangements that complement their quality and recall procedures.
Support can include:
- crisis-management plan development and review
- crisis-team structure, roles and escalation criteria
- incident and crisis-management training
- crisis-communications planning
- scenario-based crisis simulations
- business-continuity alignment
Our aim is to help the organisation maintain control, protect patients, meet its regulatory responsibilities and manage the wider operational and reputational consequences of the event.
Why choose RQA?
⋅ Product recall and crisis-management experts
RQA specialises in product recall, product risk and crisis management, supporting manufacturers, insurers and legal teams before and during product incidents.
⋅ Pharmaceutical and regulatory expertise
Our consultants bring experience across pharmaceutical quality assurance, manufacturing, distribution, GMP/GDP compliance, regulatory affairs and specialist QP/RP activities.
⋅ Support for insurers and insured companies
We understand the different requirements of underwriters, risk engineers, claims teams and pharmaceutical businesses. Our work translates technical pharmaceutical risks into clear findings, practical recommendations and proportionate risk improvements.
⋅ Practical, tailored delivery
Every assignment is scoped around the organisation’s products, supply chain, markets, regulatory responsibilities and existing level of preparedness.
⋅ Global support
RQA works internationally through a network of more than 150 experienced consultants, providing access to appropriate expertise across markets and disciplines.
⋅ Independent perspective
Our independent assessments help insurers and pharmaceutical companies identify weaknesses that may be difficult to recognise from inside an organisation.
Discuss your pharmaceutical recall risks
Whether you are underwriting a pharmaceutical product recall risk, reviewing the preparedness of an insured company or strengthening your own recall and crisis-management arrangements, RQA can help.
Tell us about the organisation, products, markets or risks you need to assess, and we will help define an appropriate scope of support.